Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape


Gilead Sciences Inc. ( GILD ) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GILD, as the stock is now down almost 18% in the past one-month time frame.

This biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

Gilead Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the same sector include Alexion Pharmaceuticals, Inc. ( ALXN ), Myriad Genetics Inc. ( MYGN ) and ANI Pharmaceuticals, Inc. ( ANIP ). ANI pharma and Myriad Genetics carry a Zacks Rank #1 (Strong Buy) while Alexion carries Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

ALKERMES INC (ALKS): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

MYRIAD GENETICS (MYGN): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: ALKS , ANIP , GILD , MYGN

More from

Related Videos



Most Active by Volume

  • $131.16 ▼ 1.12%
    $9.33 unch
  • $15.67 ▲ 0.71%
  • $49.12 ▲ 2.27%
  • $20.07 ▲ 0.50%
  • $15.805 ▼ 0.60%
  • $34.905 ▲ 2.39%
  • $3.92 ▼ 0.76%
As of 4/28/2015, 02:33 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by